期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

儿童慢性肾脏病钙磷代谢问题 被引量：3

Calcium and phosphorus metabolism in chronic kidney disease in children
原文传递
导出
摘要 钙磷代谢紊乱是儿童慢性肾脏病（chronic kidney disease，CKD）的重要并发症之一。2005年提高全球肾脏病预后国际组织（kidneydisease：improving Global Outcomes，KDIGO）明确提出“慢性肾脏病的矿物质和骨代谢异常（CKD mineral and bone disorder，CKD—MBD）”这一概念，将其定义为：CKD进展过程中由于肾功能损害导致机体钙磷代谢紊乱有关的全身性系统性疾病，
作者 王平 黄文彦
机构地区 上海交通大学附属儿童医院
出处 《中国实用儿科杂志》 CSCD 北大核心 2011年第6期411-414,共4页 Chinese Journal of Practical Pediatrics
关键词 慢性肾脏病 钙磷代谢 血管钙化 儿童 chronic kidney disease （CKD） calcium and phosphorus metabolism vascular calcification child
分类号 R72 [医药卫生—儿科]
  • 相关文献

参考文献22

  • 1Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease : improving global outcomes (KDIGO) [J]. Kidney Int, 2006,69: 1945-1953.
  • 2Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate ear- ly kidney disease [ J ]. Kidney Int, 2007,71 : 31-38.
  • 3Shroff R. Dysregulatcd mineral metabolism in children with chronic kidney disease [J]. Curr Opin Nephrol Hypertens. 2011, 20(3) : 233-240.
  • 4McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease [J]. N Engl J Med, 2004, 350: 2654-2662.
  • 5Parekh RS, CarrollCE, Wolfe RA, et al. Cardiovascular mortal- ity in children and young adults with end-stage kidney disease [J]. J Pediatr, 2002, 141 (2) : 191-197.
  • 6Oh J, Wunsch R, Turzer M, et al. Advanced coronary and ca-rotid arteriopathy in young adults with childhood-onset chronic renal failure[J]. Circulation, 2002,106( 1 ) : 100-105.
  • 7Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study[J]. Kidney Int, 2002,61 ( 1 ) :621-629.
  • 8MeCullough PA, Jurkovitz CT, Pergola PE, et ah Independent components of chronic kidney disease as a cardiovascular risk state: result from the Kidney Early Evaluation Program (KEEP) [J]. Arch Intem Med,2007,167:1122-1129.
  • 9Friedman EA. CaMum-based phosphate binders are appropri- ate in chronic renal failure [J~. Clin J Am Soc Nephrnl, 2006, 1 (4) : 704-709.
  • 10Mitsnefes MM, Kimball TR, Kartal J, et al. Cardiac and vaseu lar adaptation in pediatric patients with chronic kidney disease role of calcium-phosphorus metabolism [ J ]. J Am Soc Nephrol 2005,16 : 2796-2803.

二级参考文献14

  • 1Kestenbaum B,Sampson JN,Rudser KD,et al.Serum phosphate levels and mortality risk among people with chronic kidney disease.J Am Soc Nephrol,2005,16:520-528.
  • 2Block GA,Klassen PS,Lazarus JM,et al.Mineral metabolism,mortality,and morbidity in maintenance hemodialysis.J Am Soc Nephrol,2004,15:2208-2218.
  • 3Kuro-o M.Klotho in chronic kidney disease-what's new? Nephrol Dial Transplant,2009,24:1705-1708.
  • 4Ketteler M,Biggar PH.As nature did not predict dialysis-what we can learn from FGF23 in end-stage renal disease? Nephrol Dial Transplant,2009,24:2618-2620.
  • 5Wetmore JB,Quarles LD.Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease:time for a paradigm shift? Nat Clin Pract Nephrol,2009,5:24-33.
  • 6London GM.Bone-vascular axis in chronic kidney disease:a reality? Clin J Am Soc Nephrol,2009,4:254-257.
  • 7Mizobuchi M,Towler D,Slatopolsky E.Vascular calcification:the killer of patients with chronic kidney disease.J Am Soc Nephrol,2009,20:1453-1464.
  • 8Ketteler M,Schlieper G,Floege J.Calcification and cardiovascular health:new insights into an old phenomenon.Hypertension,2006,47:1027-1034.
  • 9Huang JC,Sakata T,Pfleger LL,et al.PTH differentially regulates expression of RANKL and OPG.J Bone Miner Res,2004,19:235-244.
  • 10West SL,Swan VJ,Jamal SA.Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.Clin J Am Soc Nephrol,2010,5 Suppl 1:S41 -S47.

共引文献5

同被引文献41

  • 1叶瑞珍.微量元素在儿童生长发育过程中作用的探讨[J].继续医学教育,2012,26(3):54-55. 被引量：4
  • 2丁小强,廖履坦,吴兆龙,蔡幼德,竺艳娟,山根兴.尿毒症贫血与红细胞生成素及有关影响因素的研究[J].中华肾脏病杂志,1995,11(4):194-196. 被引量：19
  • 3姜淑娟,王英田,白雪丽,李怀臣,陈方方.1,25二羟基维生素D_3对肺腺癌细胞株生长及凋亡的影响[J].肿瘤防治杂志,2005,12(20):1542-1545. 被引量：11
  • 4谭丽玲,贾龙梅,习卫民,汪健,房向东.肾病综合征、尿毒症患者血清生长激素水平检测及其意义[J].江西医学院学报,2006,46(3):100-101. 被引量：3
  • 5胡亚美 江载芳 诸福棠.实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1900.
  • 6Sugden JA, Davies Jl, Witham MD, et al. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels L J ]. Diabet Med, 2008,25 (3) :320-325.
  • 7For'man JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of lhe renin-angiotensin system in humans[J]. Hyper- tension, 2010,55(5) :1283-1288.
  • 8Zittermann A, Sehleithoff SS, Tenderieh G, et al. Low vitamin D status : A contributing factor in the pathogenesis of congestive heart failure[ J ]. Am Coll Cardiol, 2003,41 ( 1 ) : 105-112.
  • 9Rashid G, Bernheim J, Green J, et al. Parathyroid hormone stim- ulates endothelial expression of atherosclerotic parameters through protein kinase pathways[ J]. Am J Physiol Renal Physiol, 2007, 292(4) :F1215-1218.
  • 10Linhartov6 K, Veselka J, SterbOkova G, et al. Parathyroid hor- mone and vitamin D levels are independently associated with cal- cific aortic stenosis[J]. Circ J, 2008,72(2) :245-250.

引证文献3

二级引证文献9

中国实用儿科杂志
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部